[Cardiovascular disorders and hyperkalemia following succinylcholine].
D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control; D001919:Bradycardia / Q000139:chemically induced / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004562:Electrocardiography; D006323:Heart Arrest / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000517:prevention & control; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D012769:Shock / Q000139:chemically induced / Q000517:prevention & control; D013390:Succinylcholine / Q000009:adverse effects; D013610:Tachycardia / Q000139:chemically induced / Q000517:prevention & control; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000517:prevention & control
D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine
Kardiovasculäre Störungen und Hyperkaliämie nach Succinylcholin.